EMA accepts oral MS treatment Teriflunomide marketing app.

Aubagio is an oral treatment approved for MS.

EMA accepts oral MS treatment Teriflunomide marketing app.

Postby MSUK » Thu Feb 23, 2012 9:02 am

EMA accepts oral MS treatment Teriflunomide marketing application


Genzyme, a Sanofi company , announced today the European Medicines Agency (EMA) has accepted the filing of the marketing authorization application (MAA) for once-daily oral teriflunomide for the treatment of relapsing forms of multiple sclerosis (MS). Acceptance of the MAA starts the EMA's review process.

"The filing represents another important milestone for teriflunomide and brings us one step closer to offering a new treatment option to patients with relapsing MS," said Bill Sibold, Senior Vice President, Head of Multiple Sclerosis, Genzyme. "As an oral therapy with a promising clinical profile, teriflunomide is extremely well positioned to provide an alternative therapeutic option to patients who are currently taking injectable therapies. Those injectable therapies make up approximately 80 percent of the MS market today."... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2933
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to Aubagio (teriflunomide)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service